Brief: Nuformix Plc Provides NXP002 Update

Nuformix

27/03/2023 08:36

March 27 (Reuters) - Nuformix PLC  NFXN.L :
    * NUFORMIX PLC - NXP002 IS WELL TOLERATED IN EX-VIVO HUMAN
LUNG
TISSUE WITH NO SIGNS OF TOXICITY EVENTS

Source text for Eikon:  ID:nRSa2322Ua 
Further company coverage:  NFXN.L 

 ((Reuters.Briefs@thomsonreuters.com;;))